Slovenia, Aug. 11 -- Slovenia based Med Gen-Sol Kft has secured contract from ONKOLOSKI INSTITUT LJUBLJANA for Pharmaceutical Products - Genomic Testing for the Planning of Early Breast Cancer Treatment. The value of the contract is worth 26550000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....